Page 170 - Sách năm 2022 - Fulltext - hieu final

22. Poyurovsky M., Epshtein S., Fuchs C., Schneidman M., Weizman R., et al. (2003). "Efficacy of
low-dose mirtazapine in neuroleptic-induced akathisia: a double-blind randomized placebo-controlled pilot

study". J Clin Psychopharmacol, 23: 305-8.
23. Pringsheim T., Gardner D., Addington D., Martino D., Morgante F., et al. (2018). "The
Assessment and Treatment of Antipsychotic-Induced Akathisia". Can J Psychiatry, 63: 719-729.

24. Rummel-Kluge C., Komossa K., Schwarz S., Hunger H., Schmid F., et al. (2012). "Second-
generation antipsychotic drugs and extrapyramidal side effects: a systematic review and meta-analysis of

head-to-head comparisons". Schizophr Bull, 38: 167-77.
25. Sachdev P., Kruk J. (1994). "Clinical characteristics and predisposing factors in acute drug-
induced akathisia". Arch Gen Psychiatry, 51: 963-74.

26. Shear M. K., Frances A., Weiden P. (1983). "Suicide associated with akathisia and depot
fluphenazine treatment". J Clin Psychopharmacol, 3: 235-6.
27. Shirzadi A. A., Ghaemi S. N. (2006). "Side effects of atypical antipsychotics: extrapyramidal

symptoms and the metabolic syndrome". Harv Rev Psychiatry, 14: 152-64.
28. Stahl S. M., Lonnen A. J. (2011). "The Mechanism of Drug-induced Akathsia". CNS Spectr.
29. Tandon R., Jibson M. D. (2002). "Extrapyramidal side effects of antipsychotic treatment: scope

of problem and impact on outcome". Ann Clin Psychiatry, 14: 123-9.
30. Van Putten T., Marder S. R. (1987). "Behavioral toxicity of antipsychotic drugs". J Clin

Psychiatry, 48 Suppl: 13-9.
31. Young S. L., Taylor M., Lawrie S. M. (2015). ""First do no harm." A systematic review of the
prevalence and management of antipsychotic adverse effects". J Psychopharmacol, 29: 353-62.

32. Scholten M. R., Selten J. P. (2005). "[Suicidal ideations and suicide attempts after starting on
aripiprazole, a new antipsychotic drug]". Ned Tijdschr Geneeskd, 149: 2296-8.

170